MedTrace Logo

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

NCT05671887 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2024-11-14

No results posted yet for this study

Summary

This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.

Conditions

Interventions

PROCEDURE

Double Lung Transplantation

To evaluate outcomes among patients who undergo lung transplantation for treatment of a select group of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.

Sponsors & Collaborators

Principal Investigators

  • Young Chae, MD MPH MBA · Northwestern University

  • Ankit Bharat, MD · Northwestern University

  • Rade Tomic, MD · Northwestern University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2032-11-30
Completion
2032-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05671887 on ClinicalTrials.gov